Fennec Pharmaceuticals (FENC) Return on Equity: 2011-2025
Historic Return on Equity for Fennec Pharmaceuticals (FENC) over the last 14 years, with Sep 2025 value amounting to 1.08%.
- Fennec Pharmaceuticals' Return on Equity rose 79.00% to 1.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.08%, marking a year-over-year increase of 79.00%. This contributed to the annual value of 0.05% for FY2024, which is 221.00% down from last year.
- As of Q3 2025, Fennec Pharmaceuticals' Return on Equity stood at 1.08%, which was down 37.64% from 1.73% recorded in Q2 2025.
- Over the past 5 years, Fennec Pharmaceuticals' Return on Equity peaked at 321.08% during Q3 2023, and registered a low of -231.58% during Q4 2022.
- Over the past 3 years, Fennec Pharmaceuticals' median Return on Equity value was 2.36% (recorded in 2025), while the average stood at 32.20%.
- As far as peak fluctuations go, Fennec Pharmaceuticals' Return on Equity skyrocketed by 32,476bps in 2023, and later crashed by 32,080bps in 2024.
- Fennec Pharmaceuticals' Return on Equity (Quarterly) stood at -0.79% in 2021, then plummeted by 289bps to -231.58% in 2022, then soared by 24,699bps to 15.41% in 2023, then plummeted by 1,544bps to -0.03% in 2024, then soared by 79bps to 1.08% in 2025.
- Its last three reported values are 1.08% in Q3 2025, 1.73% for Q2 2025, and 2.36% during Q1 2025.